Drug Shortage Report for RAN-ROPINIROLE
| Report ID | 167432 |
| Drug Identification Number | 02314088 |
| Brand name | RAN-ROPINIROLE |
| Common or Proper name | ROPINIROLE |
| Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPINIROLE |
| Strength(s) | 5.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N04BC |
| ATC description | DOPAMINERGIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-03 |
| Estimated end date | 2023-10-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-08-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-08-19 | French | Compare |
| v1 | 2022-08-19 | English | Compare |